Different aminoglycoside-resistant phenotypes in a rabbit Staphylococcus aureus endocarditis infection model
- PMID: 11959609
- PMCID: PMC127149
- DOI: 10.1128/AAC.46.5.1591-1593.2002
Different aminoglycoside-resistant phenotypes in a rabbit Staphylococcus aureus endocarditis infection model
Abstract
The impact of different types of enzymatic resistance on the in vivo antibacterial activity of aminoglycosides (amikacin, gentamicin, and netilmicin) was studied in the rabbit endocarditis model with four strains of Staphylococcus aureus. Animals were treated in a manner simulating the administration of a single daily human dose. Amikacin had no effect on the three kanamycin-resistant strains despite apparent susceptibility in the disk diffusion test. Gentamicin appears to be the preferable aminoglycoside for treatment of staphylococcal infections.
References
-
- Bismuth, R. 1985. Cocci à Gram positif et aminosides, p. 29-39. In P. Courvalin, F. Goldstein, A. Philippon, and J. Sirot (ed.), L'Antibiogramme. MPC-Vigot, Paris, France.
-
- Bismuth, R., and J. Caillon. 1990. Staphylocoques, p. 187-212. In P. Courvalin, H. B. Drugeon, J. P. Flandrois, and F. Goldstein, (ed.), Bactéricidie. Maloine, Paris, France.
-
- Bugnon, D., G. Potel, J. Caillon, D. Baron, H. B. Drugeon, M. F. Kergueris, and P. Feigel. 1998. In vivo simulation of human pharmacokinetics in the rabbit. Bull. Math. Biol. 60:545-567. - PubMed
-
- Comité de l'Antibiogramme de la Société Française de Microbiologie. 1999. Communiqué 1999. Pathol. Biol. 45:I-XII.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical